BioCentury
ARTICLE | Company News

Novartis, Speedel deal

September 29, 2008 7:00 AM UTC

Novartis completed its previously announced CHF130 per share tender offer for Speedel and now holds 99.8% of the outstanding shares. Remaining shares will be cancelled under the same terms of the tend...